These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 26921953)

  • 1. The Role of Chemokine and Glycosaminoglycan Interaction in Chemokine-Mediated Migration In Vitro and In Vivo.
    del Molino del Barrio I; Kirby J; Ali S
    Methods Enzymol; 2016; 570():309-33. PubMed ID: 26921953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting Chemokine-Glycosaminoglycan Interactions to Inhibit Inflammation.
    Crijns H; Vanheule V; Proost P
    Front Immunol; 2020; 11():483. PubMed ID: 32296423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multimerization of monocyte chemoattractant protein-1 is not required for glycosaminoglycan-dependent transendothelial chemotaxis.
    Ali S; Palmer AC; Fritchley SJ; Maley Y; Kirby JA
    Biochem J; 2001 Sep; 358(Pt 3):737-45. PubMed ID: 11535134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemokine cooperativity is caused by competitive glycosaminoglycan binding.
    Verkaar F; van Offenbeek J; van der Lee MMC; van Lith LHCJ; Watts AO; Rops ALWMM; Aguilar DC; Ziarek JJ; van der Vlag J; Handel TM; Volkman BF; Proudfoot AEI; Vischer HF; Zaman GJR; Smit MJ
    J Immunol; 2014 Apr; 192(8):3908-3914. PubMed ID: 24639348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycosaminoglycans interact selectively with chemokines and modulate receptor binding and cellular responses.
    Kuschert GS; Coulin F; Power CA; Proudfoot AE; Hubbard RE; Hoogewerf AJ; Wells TN
    Biochemistry; 1999 Sep; 38(39):12959-68. PubMed ID: 10504268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution of the putative heparan sulfate-binding motif BBXB of RANTES to transendothelial migration.
    Ali S; Fritchley SJ; Chaffey BT; Kirby JA
    Glycobiology; 2002 Sep; 12(9):535-43. PubMed ID: 12213786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetics of chemokine-glycosaminoglycan interactions control neutrophil migration into the airspaces of the lungs.
    Tanino Y; Coombe DR; Gill SE; Kett WC; Kajikawa O; Proudfoot AE; Wells TN; Parks WC; Wight TN; Martin TR; Frevert CW
    J Immunol; 2010 Mar; 184(5):2677-85. PubMed ID: 20124102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A guide to chemokines and their receptors.
    Hughes CE; Nibbs RJB
    FEBS J; 2018 Aug; 285(16):2944-2971. PubMed ID: 29637711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A non-glycosaminoglycan-binding variant of CC chemokine ligand 7 (monocyte chemoattractant protein-3) antagonizes chemokine-mediated inflammation.
    Ali S; Robertson H; Wain JH; Isaacs JD; Malik G; Kirby JA
    J Immunol; 2005 Jul; 175(2):1257-66. PubMed ID: 16002730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemokine patterning by glycosaminoglycans and interceptors.
    Rot A
    Front Biosci (Landmark Ed); 2010 Jan; 15(2):645-60. PubMed ID: 20036838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycosaminoglycan binding and oligomerization are essential for the in vivo activity of certain chemokines.
    Proudfoot AE; Handel TM; Johnson Z; Lau EK; LiWang P; Clark-Lewis I; Borlat F; Wells TN; Kosco-Vilbois MH
    Proc Natl Acad Sci U S A; 2003 Feb; 100(4):1885-90. PubMed ID: 12571364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemokines and other GPCR ligands synergize in receptor-mediated migration of monocyte-derived immature and mature dendritic cells.
    Gouwy M; Struyf S; Leutenez L; Pörtner N; Sozzani S; Van Damme J
    Immunobiology; 2014 Mar; 219(3):218-29. PubMed ID: 24268109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential chemokine activation of CC chemokine receptor 1-regulated pathways: ligand selective activation of Galpha 14-coupled pathways.
    Tian Y; New DC; Yung LY; Allen RA; Slocombe PM; Twomey BM; Lee MMK; Wong YH
    Eur J Immunol; 2004 Mar; 34(3):785-795. PubMed ID: 14991608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methods for the Recognition of GAG-Bound Chemokines.
    Bonvin P; Gueneau F; Fischer N; Proudfoot A
    Methods Enzymol; 2016; 570():73-85. PubMed ID: 26921942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of chemokine-glycosaminoglycan interactions in donor tissue reduces mouse allograft vasculopathy and transplant rejection.
    Dai E; Liu LY; Wang H; McIvor D; Sun YM; Macaulay C; King E; Munuswamy-Ramanujam G; Bartee MY; Williams J; Davids J; Charo I; McFadden G; Esko JD; Lucas AR
    PLoS One; 2010 May; 5(5):e10510. PubMed ID: 20463901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Understanding the mechanisms that facilitate specificity, not redundancy, of chemokine-mediated leukocyte recruitment.
    Dyer DP
    Immunology; 2020 Aug; 160(4):336-344. PubMed ID: 32285441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of Chemokine Function: The Roles of GAG-Binding and Post-Translational Nitration.
    Thompson S; Martínez-Burgo B; Sepuru KM; Rajarathnam K; Kirby JA; Sheerin NS; Ali S
    Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28771176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemotaxis in a lymphocyte cell line transfected with C-C chemokine receptor 2B: evidence that directed migration is mediated by betagamma dimers released by activation of Galphai-coupled receptors.
    Arai H; Tsou CL; Charo IF
    Proc Natl Acad Sci U S A; 1997 Dec; 94(26):14495-9. PubMed ID: 9405641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CXCL17 binds efficaciously to glycosaminoglycans with the potential to modulate chemokine signaling.
    Giblin SP; Ranawana S; Hassibi S; Birchenough HL; Mincham KT; Snelgrove RJ; Tsuchiya T; Kanegasaki S; Dyer D; Pease JE
    Front Immunol; 2023; 14():1254697. PubMed ID: 37942327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kaposi's sarcoma-associated herpesvirus-G protein-coupled receptor-expressing endothelial cells exhibit reduced migration and stimulated chemotaxis by chemokine inverse agonists.
    Couty JP; Lupu-Meiri M; Oron Y; Gershengorn MC
    J Pharmacol Exp Ther; 2009 Jun; 329(3):1142-7. PubMed ID: 19258523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.